EngenderHealth
13
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
91.7%
+5.2% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
EPI, a Missed Opportunity for Postpartum Family Planning Utilization
Role: collaborator
An Evaluation of Re:MIX: a Teen Pregnancy Prevention Program With Young Parents as Peer Educators, EngenderHealth
Role: collaborator
Using Cultural Ceremonies to Reduce Intimate Partner Violence and HIV Transmission
Role: collaborator
Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence
Role: collaborator
Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial
Role: lead
Simplifying the Shang Ring Technique for Circumcision of Men and Boys
Role: lead
Screen and Treat for Cervical Cancer Prevention
Role: collaborator
Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
Role: collaborator
Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery
Role: lead
Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya
Role: lead
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
Role: collaborator
Comparison of the Shang Ring With Conventional Surgical Methods
Role: collaborator
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Role: collaborator
All 13 trials loaded